–
Closing
–
1D
–
YTD
Market cap
-
52 week high
-
52 week low
-
Volume
-
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
-
Analysts' Rating
-
Price Target (Mean)
-
Total Analysts
0
P/E
-
Operating Margin
-
Beta
-
Revenue Growth (Annual)
-203.51%
52 week high
-
52 week low
-
Div. Yield
-
EPS Annual Growth
-
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Analytica Limited is an Australia-based product development and commercialization company that is focused on Class I and II medical device products. Its lead product is the PeriCoach System- an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to a cloud database where physicians can monitor patient progress via Web portal. The Company is also the developer of the Enhanced Infusion System (EIS), a combination of technologies developed under the project names AutoStart and AutoFlush. It is also commercializing the AutoStart Burette infusion system. The EIS is a simple and inexpensive IV add-in technology to reduce nursing monitoring costs, reduce embolism risk, improve infection control and automatically restart flow after medication delivery during intravenous fluid infusion.
